Answers are grounded in this paper and cite their sources.
Diabetic nephropathy (DN) is known as one of the most critical microvascular complications associated with diabetes mellitus, and is a primary cause of chronic kidney disease and end-stage renal disease worldwide. Renal injury in DN is primarily driven by persistent hyperglycemia, which sequentially triggers oxidative stress, activation of innate immune signaling pathways, pro-inflammatory cytokine production, accumulation of advanced glycation end products, activation of the renin–angiotensin–aldosterone system (RAAS), and extracellular matrix deposition. Exisitng treatments, such as glycemic control, antihypertensive agents, and RAAS inhibitors, are efficacious in slowing disease progression. Alongside these standard therapies, medicinal plants and their bioactive constituents have garnered substantial attention as potential complementary approaches. The aim of this review is to highlight the therapeutic potential of medicinal plants and their phytoconstituents, leading to the prevention and management of DN, while elucidating associated pharmacological mechanisms. Several in vitro and in vivo studies have shown that various medicinal plants exert nephroprotective effects through antihyperglycemic, antioxidant, anti-inflammatory, anti-apoptotic, and lipid-lowering mechanisms, as well as by inactivating innate immune pathways. Notable phytoconstituents, including quercetin, rutin, curcumin, berberine, mangiferin, gallic acid, and thymoquinone, have demonstrated promising potential in enhancing renal biomarkers, reducing oxidative stress, suppressing inflammatory mediators, and preserving renal tissue structure. Altogether, medicinal plants emerge as promising multi-target therapeutic candidates for DN, warranting rigorous clinical trials to better evaluate their future therapeutic translation.
No takes yet. Share an insight, caveat, or question.
Akther et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: